Literature DB >> 7888069

Human herpesvirus 6 in AIDS.

P Lusso1, R C Gallo.   

Abstract

Multiple lines of clinical and experimental evidence suggest that human herpesvirus 6 (HHV-6) may act as an accelerating factor in the natural history of human immunodeficiency virus (HIV) infection. Although, in common with HIV, HHV-6 has a primary tropism for CD4+ T cells, its potential effects on the immune system are broader. For instance, HHV-6 can also infect and kill CD8+ T cells, natural killer cells and mononuclear phagocytes. Here, Paolo Lusso and Robert Gallo suggest that understanding the immunopathogenic role of HHV-6 in the course of HIV infection may shed new light on the complex mechanisms of disease progression in AIDS.

Entities:  

Mesh:

Year:  1995        PMID: 7888069     DOI: 10.1016/0167-5699(95)80090-5

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


  39 in total

1.  Highly active antiretroviral therapy and beta-chemokines.

Authors:  B Brichacek; M Bukrinsky
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

2.  Prospective study of human herpesvirus 6, human herpesvirus 7, and cytomegalovirus infections in human immunodeficiency virus-positive patients.

Authors:  G Fabio; S N Knight; I M Kidd; S M Noibi; M A Johnson; V C Emery; P D Griffiths; D A Clark
Journal:  J Clin Microbiol       Date:  1997-10       Impact factor: 5.948

3.  CD68+ cells of monocyte/macrophage lineage in the environment of AIDS-associated and classic-sporadic Kaposi sarcoma are singly or doubly infected with human herpesviruses 7 and 6B.

Authors:  W Kempf; V Adams; N Wey; R Moos; M Schmid; E Avitabile; G Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  1997-07-08       Impact factor: 11.205

Review 4.  HIV and the chemokine system: 10 years later.

Authors:  Paolo Lusso
Journal:  EMBO J       Date:  2006-01-26       Impact factor: 11.598

Review 5.  Central nervous system infection during immunosuppression.

Authors:  Joseph R Zunt
Journal:  Neurol Clin       Date:  2002-02       Impact factor: 3.806

6.  The U24 protein from human herpesvirus 6 and 7 affects endocytic recycling.

Authors:  Brian M Sullivan; Laurent Coscoy
Journal:  J Virol       Date:  2009-11-18       Impact factor: 5.103

7.  Expression of human herpesvirus-6 antigens in benign and malignant lymphoproliferative diseases.

Authors:  M Luppi; P Barozzi; R Garber; A Maiorana; G Bonacorsi; T Artusi; R Trovato; R Marasca; G Torelli
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

8.  Viral glycoproteins accumulate in newly formed annulate lamellae following infection of lymphoid cells by human herpesvirus 6.

Authors:  G Cardinali; M Gentile; M Cirone; C Zompetta; L Frati; A Faggioni; M R Torrisi
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

9.  Phenotypic and functional alterations of dendritic cells induced by human herpesvirus 6 infection.

Authors:  Miki Kakimoto; Atsuhiko Hasegawa; Shigeru Fujita; Masaki Yasukawa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

Review 10.  Laboratory and clinical aspects of human herpesvirus 6 infections.

Authors:  Henri Agut; Pascale Bonnafous; Agnès Gautheret-Dejean
Journal:  Clin Microbiol Rev       Date:  2015-04       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.